A detailed history of Strategy Asset Managers LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Strategy Asset Managers LLC holds 7,975 shares of BSX stock, worth $666,869. This represents 0.12% of its overall portfolio holdings.

Number of Shares
7,975
Previous 10,439 23.6%
Holding current value
$666,869
Previous $714,000 14.01%
% of portfolio
0.12%
Previous 0.15%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

SELL
$67.33 - $77.71 $165,901 - $191,477
-2,464 Reduced 23.6%
7,975 $614,000
Q1 2024

Apr 25, 2024

BUY
$57.6 - $68.62 $92,448 - $110,135
1,605 Added 18.17%
10,439 $714,000
Q4 2023

Feb 12, 2024

BUY
$48.64 - $57.81 $7,441 - $8,844
153 Added 1.76%
8,834 $510,000
Q3 2023

Nov 09, 2023

BUY
$50.19 - $54.68 $35,434 - $38,604
706 Added 8.85%
8,681 $458,000
Q2 2023

Aug 24, 2023

SELL
$49.72 - $54.64 $9,297 - $10,217
-187 Reduced 2.29%
7,975 $431,000
Q1 2023

May 02, 2023

BUY
$45.09 - $50.03 $14,924 - $16,559
331 Added 4.23%
8,162 $408,000
Q4 2022

Jan 13, 2023

SELL
$39.56 - $47.22 $2,136 - $2,549
-54 Reduced 0.68%
7,831 $362,000
Q3 2022

Oct 11, 2022

BUY
$36.71 - $109.66 $289,458 - $864,669
7,885 New
7,885 $305,000
Q1 2022

Apr 11, 2022

SELL
$40.9 - $45.1 $331,617 - $365,670
-8,108 Closed
0 $0
Q4 2021

Jan 14, 2022

BUY
$38.07 - $44.87 $308,671 - $363,805
8,108 New
8,108 $344,000
Q2 2019

Aug 14, 2019

SELL
$34.91 - $42.98 $16,756 - $20,630
-480 Closed
0 $0
Q1 2019

May 08, 2019

SELL
$32.91 - $40.75 $1.59 Million - $1.97 Million
-48,383 Reduced 99.02%
480 $18,000
Q4 2018

Feb 14, 2019

SELL
$31.73 - $39.04 $1.37 Million - $1.69 Million
-43,191 Reduced 46.92%
48,863 $1.73 Million
Q3 2018

Nov 01, 2018

BUY
$32.83 - $38.63 $3.02 Million - $3.56 Million
92,054 New
92,054 $0

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $120B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Strategy Asset Managers LLC Portfolio

Follow Strategy Asset Managers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategy Asset Managers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strategy Asset Managers LLC with notifications on news.